CSF-1R inhibition alters macrophage polarization and blocks glioma progression

Pyonteck, Stephanie M, Akkari, Leila, Schuhmacher, Alberto J, Bowman, Robert L, Sevenich, Lisa, Quail, Daniela F, Olson, Oakley C, Quick, Marsha L +12 more·2013·Nature Medicine
DOI 10.1038/nm.3337

Cited by (1,005)

Items 401–500 of 1,005

  1. Modulating the polarization phenotype of microglia – A valuable strategy for central nervous system diseases
    Yu Long, Xiaoqiu Li, Jie Deng, Qiaobo Ye, Dan Li, Yin Ma, Yuanyuan Wu, Yue Hu, Xiao-fang He, Jing Wen et al. · 2023 · Ageing Research Reviews
  2. CSF-1/CSF-1R targeting agents in clinical development for cancer therapy
    Carola Hermine Ries, Sabine Hoves, Michael A. Cannarile, Dominik Rüttinger · 2015 · Current Opinion in Pharmacology
  3. ICAM-1 suppresses tumor metastasis by inhibiting macrophage M2 polarization through blockade of efferocytosis
    Min Hee Yang, Jing Liu, Chunmei Piao, J Shao, Juan Du · 2015 · Cell Death and Disease
  4. Macrophage Blockade Using CSF1R Inhibitors Reverses the Vascular Leakage Underlying Malignant Ascites in Late-Stage Epithelial Ovarian Cancer
    Diana L. Moughon, Huanhuan He, Shiruyeh Schokrpur, Ziyue Karen Jiang, Madeeha Yaqoob, John David, Crystal D. Lin, M. Luisa Iruela‐Arispe, Oliver Dorigo, Lily Wu · 2015 · Cancer Research
  5. Immunotherapies for malignant glioma
    Vassiliki A. Boussiotis, Alain Charest · 2017 · Oncogene
  6. Nano-enhanced immunotherapy: Targeting the immunosuppressive tumor microenvironment
    Yuzhi Jin, Yangyue Huang, Hui Ren, Huanhuan Huang, Chunyu Lai, Wenjun Wang, Zhou Tong, Hangyu Zhang, Wei Wu, Chuan Liu et al. · 2024 · Biomaterials
  7. A Carbon Nanotube Optical Reporter Maps Endolysosomal Lipid Flux
    Jena, Prakrit V., Roxbury, Daniel, Galassi, Thomas V., Akkari, Leila, Horoszko, Christopher P., Iaea, David B., Budhathoki-Uprety, Januka, Pipalia, Nina, Haka, Abigail S., Harvey, Jackson D. et al. · 2017 · ACS Nano
  8. Tumor-associated macrophages and anti-tumor therapies: complex links
    Cristina Belgiovine, Maurizio D’Incalci, Paola Allavena, Roberta Frapolli · 2016 · Cellular and Molecular Life Sciences
  9. Hydroxychloroquine induced lung cancer suppression by enhancing chemo-sensitization and promoting the transition of M2-TAMs to M1-like macrophages
    Yong Li, Fengjun Cao, Mingxing Li, Pindong Li, Yuandong Yu, Longchao Xiang, Tao Xu, Jinhua Lei, Yunyan Tai, Jianyong Zhu et al. · 2018 · Journal of Experimental & Clinical Cancer Research
  10. MHC class II-restricted antigen presentation is required to prevent dysfunction of cytotoxic T cells by blood-borne myeloids in brain tumors
    Michael Kilian, Ron Sheinin, Chin Leng Tan, Mirco Friedrich, Christopher Krämer, Ayelet Kaminitz, Khwab Sanghvi, Katharina A.M. Lindner, Yu‐Chan Chih, Frederik Cichon et al. · 2023 · Cancer Cell
  11. Astrocyte immunometabolic regulation of the tumour microenvironment drives glioblastoma pathogenicity
    Rita Perelroizen, Bar Philosof, Noga Budick-Harmelin, Tom Chernobylsky, Ariel Ron, Rotem Katzir, Dor Shimon, Adi Tessler, Orit Adir, Anat Gaoni-Yogev et al. · 2022 · Brain
  12. Pharmacological inhibition of CSF1R by GW2580 reduces microglial proliferation and is protective against neuroinflammation and dopaminergic neurodegeneration
    Neal, Matthew L., Fleming, Sheila M., Budge, Kevin M., Boyle, Alexa M., Kim, Chunki, Alam, Gelareh, Beier, Eric E., Wu, Long‐Jun, Richardson, Jason R. · 2020 · The FASEB Journal
  13. Inflammation as target in cancer therapy
    Giulia Marelli, Antonio Sica, Luca E. Vannucci, Paola Allavena · 2017 · Current Opinion in Pharmacology
  14. Tumor‑infiltrating M2�macrophages driven by specific genomic alterations are associated with prognosis in bladder cancer
    Yongping Xue, Liping Tong, Fei Liu, Anwei Liu, Shuxiong Zeng, Qiao Xiong, Zeyu Yang, Xing He, Yinghao Sun, Chuanliang Xu · 2019 · Oncology Reports
  15. Comparative analysis of the tumor immune-microenvironment of primary and brain metastases of non-small-cell lung cancer reveals organ-specific and EGFR mutation-dependent unique immune landscape
    Seung Geun Song, Sehui Kim, Jaemoon Koh, Jeemin Yim, Bogyeong Han, Young A Kim, Yoon Kyung Jeon, Doo Hyun Chung · 2021 · Cancer Immunology Immunotherapy
  16. Macrophage-targeted nanomedicine for chronic diseases immunotherapy
    Yuejia Song, Yaqian Huang, Fang Zhou, Jinsong Ding, Wenhu Zhou · 2021 · Chinese Chemical Letters
  17. Efficient Immunotherapy of Drug-Free Layered Double Hydroxide Nanoparticles via Neutralizing Excess Acid and Blocking Tumor Cell Autophagy
    Lingxiao Louis Zhang, Yingbo Jia, Jin-ju Yang, Lun Zhang, Shengjie Hou, Xiaoyun Niu, Jie Zhu, Yaru Huang, Xiaoying Sun, Zhi Ping Xu et al. · 2022 · ACS Nano
  18. Glioma Stem Cells and Their Microenvironments: Providers of Challenging Therapeutic Targets
    Elena Codrici, Ana‐Maria Enciu, Ionela Daniela Popescu, Simona Mihai, Cristiana Tănase · 2016 · Stem Cells International
  19. Modulation of inflammation by low and high doses of ionizing radiation: Implications for benign and malign diseases
    Benjamin Frey, Stephanie Hehlgans, Franz Rödel, Udo S. Gaipl · 2015 · Cancer Letters
  20. Oligodendrocyte Progenitor Cells and Macrophages/Microglia Produce Glioma Stem Cell Niches at the Tumor Border
    Takuichiro Hide, Yoshihiro Komohara, Yuko Miyasato, Hideo Nakamura, Keishi Makino, Motohiro Takeya, Jun‐ichi Kuratsu, Akitake Mukasa, Shigetoshi Yano · 2018 · EBioMedicine
  21. Metabolically activated adipose tissue macrophages link obesity to triple-negative breast cancer
    Payal Tiwari, Ariane Blank, Chang Cui, Kelly Q. Schoenfelt, Guolin Zhou, Yanfei Xu, Galina F. Khramtsova, Olufunmilayo Ibironke Olopade, Ajay M. Shah, Seema Ahsan Khan et al. · 2019 · The Journal of Experimental Medicine
  22. Tuning the Tumor Myeloid Microenvironment to Fight Cancer
    Nadine S. Jahchan, Adriana M. Mujal, Joshua L. Pollack, Mikhail Binnewies, Venkataraman Sriram, Leonard M. Reyno, Matthew F. Krummel · 2019 · Frontiers in Immunology
  23. Tumor-Associated Macrophages in SHH Subgroup of Medulloblastomas
    Ashley Margol, Nathan John Robison, Janahan Gnanachandran, Long T. Hung, Rebekah J. Kennedy, Marzieh Vali, Girish Dhall, Jonathan L. Finlay, Anat Erdreich‐Epstein, Mark D. Krieger et al. · 2014 · Clinical Cancer Research
  24. Distinct functions of macrophage-derived and cancer cell-derived cathepsin Z combine to promote tumor malignancy via interactions with the extracellular matrix
    Leila Akkari, Vasilena Gocheva, Jemila C. Kester, Karen E. Hunter, Marsha L. Quick, Lisa Sevenich, Hao‐Wei Wang, Christoph Peters, Laura H. Tang, David S. Klimstra et al. · 2014 · Genes & Development
  25. Mannose receptor high, M2 dermal macrophages mediate nonhealing Leishmania major infection in a Th1 immune environment
    Sang Hun Lee, Mélanie Charmoy, Audrey Romano, Andrea Paun, Mariana Martins Chaves, Frederick O. Cope, David A. Ralph, David L. Sacks · 2017 · The Journal of Experimental Medicine
  26. Collagen Density Modulates the Immunosuppressive Functions of Macrophages
    Anne Mette H. Larsen, Dorota Ewa Kuczek, Adrija Kalviša, Majken Storm Siersbæk, Marie‐Louise Thorseth, Astrid Zedlitz Johansen, Marco Carretta, Lars Grøntved, Ole Vang, Daniel Hargbøll Madsen · 2020 · The Journal of Immunology
  27. Immune Escape in Glioblastoma Multiforme and the Adaptation of Immunotherapies for Treatment
    Joshua R. D. Pearson, Stefania Cuzzubbo, Simon McArthur, Lindy G. Durrant, Jason Adhikaree, Chris J. Tinsley, Alan Graham Pockley, Stéphanie McArdle · 2020 · Frontiers in Immunology
  28. DKK1 Promotes Tumor Immune Evasion and Impedes Anti–PD-1 Treatment by Inducing Immunosuppressive Macrophages in Gastric Cancer
    Tao Shi, Yipeng Zhang, Yue Wang, Xueru Song, Hanbing Wang, Xiaoyu Zhou, Kaijie Liang, Yuting Luo, Keying Che, Xuan Wang et al. · 2022 · Cancer Immunology Research
  29. Targeting Macrophages: Friends or Foes in Disease?
    Juan Antonio Ardura, Gorjana Rackov, Elena Izquierdo, Verónica Alonso, Arancha R. Gortázar, María Marta Escribese · 2019 · Frontiers in Pharmacology
  30. SLIT2/ROBO signaling in tumor-associated microglia and macrophages drives glioblastoma immunosuppression and vascular dysmorphia
    Luiz Henrique Geraldo, Yunling Xu, Laurent Jacob, Laurence Pibouin-Fragner, Rohit Rao, Nawal Maïssa, Maïté Verreault, Nolwenn Lemaire, Camille A. Knosp, Corinne Lesaffre et al. · 2021 · Journal of Clinical Investigation
  31. Genetic targeting of microglia
    Peter Wieghofer, Klaus‐Peter Knobeloch, Marco Prinz · 2014 · Glia
  32. Macrophages-induced long noncoding RNA H19 up-regulation triggers and activates the miR-193b/MAPK1 axis and promotes cell aggressiveness in hepatocellular carcinoma
    Yingnan Ye, Jincheng Guo, Pei Gen Xiao, Junya Ning, Rui Zhang, Pengpeng Liu, Wenwen Yu, Li‐Yan Xu, Yi Chen Zhao, Jinpu Yu · 2019 · Cancer Letters
  33. Manipulating the function of tumor-associated macrophages by siRNA-loaded lipid nanoparticles for cancer immunotherapy
    Nour Shobaki, Yusuke Sato, Yuichi Suzuki, Nana Okabe, Hideyoshi Harashima · 2020 · Journal of Controlled Release
  34. Human glioblastoma‐associated microglia/monocytes express a distinct RNA profile compared to human control and murine samples
    Frank Szulzewsky, Sonali Arora, Lot D. de Witte, Thomas Ulas, Darko S. Markovic, Joachim Ludwig Schultze, Eric C. Holland, Michael Synowitz, Susanne A. Wolf, Helmut Kettenmann · 2016 · Glia
  35. Leukocyte trafficking in tumor microenvironment
    Annalisa Del Prete, Tiziana Schioppa, Laura Tiberio, Helena Stabile, Silvano Sozzani · 2017 · Current Opinion in Pharmacology
  36. CSF1R Inhibition Reduces Microglia Proliferation, Promotes Tissue Preservation and Improves Motor Recovery After Spinal Cord Injury
    Yannick Nicolas Gerber, Guillaume Saint-Martin, Claire Mathilde Bringuier, Sylvain Bartolami, Christophe Goze‐Bac, Harun Najib Noristani, Florence Evelyne Perrin · 2018 · Frontiers in Cellular Neuroscience
  37. Turning “Cold” Into “Hot” Tumors—Opportunities and Challenges for Radio-Immunotherapy Against Primary and Metastatic Brain Cancers
    Lisa Sevenich · 2019 · Frontiers in Oncology
  38. Role of Inflammatory Mediators, Macrophages, and Neutrophils in Glioma Maintenance and Progression: Mechanistic Understanding and Potential Therapeutic Applications
    Abdul Samad Basheer, Faridah Abas, Iekhsan Othman, Rakesh Naidu · 2021 · Cancers
  39. Promoting antibody-dependent cellular phagocytosis for effective macrophage-based cancer immunotherapy
    Xu Cao, Jing Chen, Bolei Li, Jessica Dang, Wencan Zhang, Xiancai Zhong, Chongkai Wang, Mustafa Raoof, Zuoming Sun, Jianhua Yu et al. · 2022 · Science Advances
  40. Combinatorial Approach to Improve Cancer Immunotherapy: Rational Drug Design Strategy to Simultaneously Hit Multiple Targets to Kill Tumor Cells and to Activate the Immune System
    Shweta Joshi, Donald L. Durden · 2019 · Journal of Oncology
  41. Fra-2–expressing macrophages promote lung fibrosis
    Alvaro Conrado Ucero, Latifa Bakiri, Ben Roediger, Masakatsu Suzuki, María Jiménez, Pratyusha Mandal, Paola Braghetta, Paolo Bonaldo, Luis G Paz-Ares, Coral Fustero Torre et al. · 2019 · Journal of Clinical Investigation
  42. Targeting Glioblastoma Stem Cells: A Review on Biomarkers, Signal Pathways and Targeted Therapy
    Xuejia Tang, Chenghai Zuo, Pengchao Fang, Guojing Liu, Yongyi Qiu, Yi Huang, Rongrui Tang · 2021 · Frontiers in Oncology
  43. Polyamines drive myeloid cell survival by buffering intracellular pH to promote immunosuppression in glioblastoma
    Jason M. Miska, Aida Rashidi, Catalina Lee-Chang, Peng Gao, Aurora Lopez‐Rosas, Peng Zhang, Rachel A. Burga, Brandyn A. Castro, Ting Xiao, Yu Han et al. · 2021 · Science Advances
  44. METTL1 promotes tumorigenesis through tRNA-derived fragment biogenesis in prostate cancer
    Raquel García-Vílchez, Ana M. Añazco-Guenkova, Sabine Dietmann, Judith López, Virginia Morón-Calvente, Silvia D’Ambrosi, Paz Nombela, Kepa Zamacola, Isabel Mendizabal, Saioa Garcia‐Longarte et al. · 2023 · Molecular Cancer
  45. The intersection of cancer, cancer stem cells, and the immune system: therapeutic opportunities
    Daniel J. Silver, Maksim Sinyuk, Michael A. Vogelbaum, Manmeet Singh Ahluwalia, Justin Durla Lathia · 2015 · Neuro-Oncology
  46. Targeting CSF-1R represents an effective strategy in modulating inflammatory diseases
    Caigui Xiang, Heng Li, Wei Tang · 2022 · Pharmacological Research
  47. Reprogramming tumor-associated macrophages as a unique approach to target tumor immunotherapy
    Safir Ullah Khan, Munir Ullah Khan, Muhammad Azhar Ud Din, Ibrar Muhammad Khan, Muhammad Imran Khan, SIMONA GABRIELA BUNGAU, Syed Shams ul Hassan · 2023 · Frontiers in Immunology
  48. Selectively targeting tumor-associated macrophages and tumor cells with polymeric micelles for enhanced cancer chemo-immunotherapy
    Wei Xiao, Lingqiao Liu, Xilin Li, Yi Wang, Xing Guo, Jingya Zhao, Shaobing Zhou · 2019 · Journal of Controlled Release
  49. Current Understanding of Hypoxia in Glioblastoma Multiforme and Its Response to Immunotherapy
    Jang Hyun Park, Heung Kyu Lee · 2022 · Cancers
  50. CTLA-4 blockade induces a microglia-Th1 cell partnership that stimulates microglia phagocytosis and anti-tumor function in glioblastoma
    Dan Chen, Siva Karthik Varanasi, Toshiro Hara, Kacie A. Traina, Ming Hua Sun, Bryan McDonald, Yagmur Farsakoglu, Josh Clanton, Shihao Xu, Lizmarie Garcia-Rivera et al. · 2023 · Immunity
  51. Tumor-associated macrophages as an emerging target against tumors: Creating a new path from bench to bedside.
    M. Jinushi, Yoshihiro Komohara · 2015 · Biochimica et Biophysica Acta
  52. Role of the Microenvironment in Glioma Pathogenesis
    Maya Anjali Jayaram, Joanna J. Phillips · 2023 · Annual Review of Pathology Mechanisms of Disease
  53. Central nervous system myeloid cells as drug targets: current status and translational challenges
    Knut P. H. Biber, Thomas Möller, Erik Boddeke, Marco Prinz · 2015 · Nature Reviews Drug Discovery
  54. Nanomedicine Strategies to Target Tumor-Associated Macrophages
    Karin Binnemars‐Postma, Gert Storm, Jai Prakash · 2017 · International Journal of Molecular Sciences
  55. 3D models in the new era of immune oncology: focus on T cells, CAF and ECM
    Francesca Di Modugno, Cristina Colosi, Paola Trono, Giuseppe Antonacci, Giancarlo Ruocco, Paola Nisticò · 2019 · Journal of Experimental & Clinical Cancer Research
  56. Tumour-associated macrophages exhibit anti-tumoural properties in Sonic Hedgehog medulloblastoma
    Victor D Maximov, Zhihong Chen, Yun Wei, M. Hope Robinson, Cameron J. Herting, Nithya Shanmugam, Vasilisa A. Rudneva, Kelly C. Goldsmith, Tobey J. MacDonald, Paul A. Northcott et al. · 2019 · Nature Communications
  57. Dual inhibition of CSF1R and MAPK pathways using supramolecular nanoparticles enhances macrophage immunotherapy
    Anujan Ramesh, Anthony Brouillard, Sahana Kumar, Dipika Nandi, Ashish A. Kulkarni · 2019 · Biomaterials
  58. A systematic review on poly(I:C) and poly-ICLC in glioblastoma: adjuvants coordinating the unlocking of immunotherapy
    Jorrit De Waele, Tias Verhezen, Sanne van der Heijden, Zwi Nisan Berneman, Marc Peeters, Filip Lardon, An Wouters, Evelien Smits · 2021 · Journal of Experimental & Clinical Cancer Research
  59. Pharmacological inhibition of BACE1 suppresses glioblastoma growth by stimulating macrophage phagocytosis of tumor cells
    Kui Zhai, Zhi Huang, Qian Huang, Weiwei Tao, Xiaoguang Fang, Aili Zhang, Xiaoxia Li, George Robert Stark, Thomas A. Hamilton, Shideng Bao · 2021 · Nature Cancer
  60. CD103+ regulatory T cells underlie resistance to radio-immunotherapy and impair CD8+ T cell activation in glioblastoma
    Luuk van Hooren, Shanna M. Handgraaf, Daan J. Kloosterman, Elham Karimi, Lotte W.H.G. van Mil, Awa A. Gassama, Beatriz Gomez Solsona, Marnix H. P. de Groot, Dieta Brandsma, Daniela F. Quail et al. · 2023 · Nature Cancer
  61. CSF1 Overexpression Promotes High-Grade Glioma Formation without Impacting the Polarization Status of Glioma-Associated Microglia and Macrophages
    Ishani De, Megan D. Steffen, Paul A. Clark, Clayton J. Patros, Emily Sokn, Stephanie M. Bishop, Suzanne J. Litscher, Vilena I. Maklakova, John S. Kuo, Fausto J. Rodríguez et al. · 2016 · Cancer Research
  62. Modulating the Tumor Microenvironment via Oncolytic Viruses and CSF-1R Inhibition Synergistically Enhances Anti-PD-1 Immunotherapy
    Gang Shi, Qianmei Yang, Yujing Zhang, Qingyuan Jiang, Yi Lin, Shenshen Yang, Huiling Wang, Lin Cheng, Xin Zhang, Yimin Li et al. · 2018 · Molecular Therapy
  63. Targeting the tumor microenvironment: Potential strategy for cancer therapeutics
    Quratulain Babar, Ayesha Saeed, Tanveer Ahmad Tabish, Mohsin Sarwar, Nanasaheb D. Thorat · 2023 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  64. The emerging roles of macrophages in cancer metastasis and response to chemotherapy
    Luis Rivera Sanchez, Lucia Borriello, David R. Entenberg, John S. Condeelis, Maja H. Oktay, George S. Karagiannis · 2019 · Journal of Leukocyte Biology
  65. Transcriptional regulatory networks of tumor-associated macrophages that drive malignancy in mesenchymal glioblastoma
    Jason K. Sa, Nakho Chang, Hye Won Lee, Hee Jin Cho, Michele Ceccarelli, Luigi Cerulo, Jinlong Yin, Sung Soo Kim, Francesca Pia Caruso, Mijeong Lee et al. · 2020 · Genome biology
  66. Corrigendum to “New Mechanisms of Tumor-Associated Macrophages on Promoting Tumor Progression: Recent Research Advances and Potential Targets for Tumor Immunotherapy”
    Qiujun Guo, Zhichao Jin, Yuan Yuan, Rui Liu, Tao Xu, Huamin Wei, Xinyao Xu, Shulin He, Shuntai Chen, Zhan Shi et al. · 2018 · Journal of Immunology Research
  67. Enhancing antibody-dependent cellular phagocytosis by Re-education of tumor-associated macrophages with resiquimod-encapsulated liposomes
    Hao Li, Masaharu Somiya, Shun’ichi Kuroda · 2020 · Biomaterials
  68. Complement 5a stimulates macrophage polarization and contributes to tumor metastases of colon cancer
    Piao, Chunmei, Zhang, Wen-Mei, Li, Tao-Tao, Zhang, Cong-cong, Qiu, Shulan, Liu, Yan, Liu, Sa, Jin, Ming, Jia, Li-Xin, Song, Wen-Chao et al. · 2018 · Experimental Cell Research
  69. In situ proliferation contributes to accumulation of tumor‐associated macrophages in spontaneous mammary tumors
    Piotr Tymoszuk, Hanneke Evens, Vanessa Marzola, Katarzyna Wachowicz, Marie-Hélène Wasmer, Sebak Datta, Elisabeth Müller‐Holzner, Heidi Fiegl, Günther Böck, Nico van Rooijen et al. · 2014 · European Journal of Immunology
  70. Hypoxia induces macrophage polarization and re-education toward an M2 phenotype in U87 and U251 glioblastoma models
    M.M. Leblond, Aurélie N. Gérault, Aurélien Corroyer‐Dulmont, Eric T. MacKenzie, Edwige Petit, Myriam Bernaudin, Samuel Valable · 2015 · OncoImmunology
  71. Designing herpes viruses as oncolytics
    Cole W. Peters, Samuel D. Rabkin · 2015 · Molecular Therapy — Oncolytics
  72. A CCR4 antagonist reverses the tumor-promoting microenvironment of renal cancer
    Chiara Berlato, Moddasar N. Khan, Tiziana Schioppa, Richard Damian Thompson, Eleni Maniati, Anne Montfort, Maryam Jangani, Monica Canosa, Hagen Kulbe, Urs B. Hagemann et al. · 2017 · Journal of Clinical Investigation
  73. Imatinib prevents lung cancer metastasis by inhibiting M2-like polarization of macrophages
    Zhangting Yao, Jieqiong Zhang, Bo Zhang, Guikai Liang, Xi Chen, Fengqi Yao, Xiaqing Xu, Honghai Wu, Qiaojun He, Ling Ding et al. · 2018 · Pharmacological Research
  74. Astrocytes enhance glioblastoma growth
    Alessandro Mega, Mette Hartmark Nilsen, Lina Wik Leiss, Nicholas P. Tobin, Hrvoje Miletić, Linda Sleire, Carina Strell, Sven Nelander, Cecilia C. Krona, Daniel Hägerstrand et al. · 2019 · Glia
  75. An epigenetic gateway to brain tumor cell identity
    Stephen C. Mack, Christopher G. Hubert, Tyler E. Miller, Michael D. Taylor, Jeremy N. Rich · 2015 · Nature Neuroscience
  76. Concentration-dependent effects of CSF1R inhibitors on oligodendrocyte progenitor cells ex vivo and in vivo
    Liu, Yiting, Given, Katherine S., Dickson, Erin L., Owens, Gregory P., Macklin, Wendy B., Bennett, Jeffrey L. · 2019 · Experimental Neurology
  77. Head and neck cancer relapse after chemoradiotherapy correlates with CD163+ macrophages in primary tumour and CD11b+ myeloid cells in recurrences
    Panagiotis Balermpas, Franz Rödel, R Liberz, Julius Oppermann, Jens Wagenblast, Shahram Ghanaati, Patrick N. Harter, Michel Guy André Mittelbronn, C Weiss, Claus Michael Rödel et al. · 2014 · British Journal of Cancer
  78. Tim-3 promotes tumor-promoting M2 macrophage polarization by binding to STAT1 and suppressing the STAT1-miR-155 signaling axis
    Xingwei Jiang, Tingting Zhou, Yan Xiao, Jiahui Yu, Shuaijie Dou, Guojiang Chen, Renxi Wang, Xiao He, Chunmei Hou, Wei Wang et al. · 2016 · OncoImmunology
  79. CSF-1R Inhibitor Development: Current Clinical Status
    Florent Peyraud, Sophie Cousin, Antoîne Italiano · 2017 · Current Oncology Reports
  80. Harnessing the antitumor potential of macrophages for cancer immunotherapy
    Kristen B. Long, Gregory Lawrence Beatty · 2013 · OncoImmunology
  81. Glioma-induced inhibition of caspase-3 in microglia promotes a tumor-supportive phenotype
    Xianli Shen, Miguel Ángel Burguillos, Ahmed M. Osman, Jeroen Frijhoff, Alejandro Carrillo-Jiménez, Sachie Kanatani, Martin Augsten, Dalel Saidi, Johanna Rodhe, Edel T. Kavanagh et al. · 2016 · Nature Immunology
  82. The network of immunosuppressive pathways in glioblastoma
    Davide Mangani, Michael Weller, Patrick Roth · 2016 · Biochemical Pharmacology
  83. Genetic and genomic alterations differentially dictate low-grade glioma growth through cancer stem cell–specific chemokine recruitment of T cells and microglia
    Xiaofan Guo, Yuan Pan, David H. Gutmann · 2019 · Neuro-Oncology
  84. Tumor‐associated macrophages in immunotherapy
    Shijia Yan, Guohui Wan · 2021 · FEBS Journal
  85. Integrated single-cell transcriptomic analyses reveal that GPNMB-high macrophages promote PN-MES transition and impede T cell activation in GBM
    Aizhen Xiong, Jiwei Zhang, Yan Chen, Yi Zhang, Fan Yang · 2022 · EBioMedicine
  86. Regulation of epithelial-mesenchymal transition by tumor microenvironmental signals and its implication in cancer therapeutics
    Jing Zhang, Zhimin Hu, Calista A. Horta, Jing Yang · 2022 · Seminars in Cancer Biology
  87. M2-polarized macrophages contribute to neovasculogenesis, leading to relapse of oral cancer following radiation
    Makiko Okubo, Mitomu Kioi, Hideyuki Nakashima, Kei Sugiura, Kenji Mitsudo, Ichio Aoki, Hideki Taniguchi, Iwai Tohnai · 2016 · Scientific Reports
  88. Tumor-associated macrophages: a short compendium
    Hans Prenen, Massimiliano Mazzone · 2019 · Cellular and Molecular Life Sciences
  89. Prognosis Analysis and Validation of m6A Signature and Tumor Immune Microenvironment in Glioma
    Shaojian Lin, Houshi Xu, Anke Zhang, Yunjia Ni, Yuanzhi Xu, Tong Meng, Mingjie Wang, Meiqing Lou · 2020 · Frontiers in Oncology
  90. Convergent inducers and effectors of T cell paralysis in the tumour microenvironment
    Douglas Hanahan, Olivier Alain Michielin, Mikaël J. Pittet · 2024 · Nature reviews. Cancer
  91. RNA Sequencing of Tumor-Associated Microglia Reveals Ccl5 as a Stromal Chemokine Critical for Neurofibromatosis-1 Glioma Growth
    Anne C. Solga, Winnie W. Pong, Keun-young Kim A, Patrick Joseph Cimino, Joseph A. Toonen, Jason Walker, Todd Wylie, Vincent J. Magrini, Malachi Griffith, Obi L. Griffith et al. · 2015 · Neoplasia
  92. Targeting FROUNT with Disulfiram Regulates Macrophage Responses in Cancer
    Yuya Terashima, Etsuko Toda, Meiji Itakura, Mikiya Otsuji, Sosuke Yoshinaga, Kazuhiro Okumura, Francis H. W. Shand, Yoshihiro Komohara, Mitsuhiro Takeda, Kana Kokubo et al. · 2018 · Nature Communications
  93. FGL2 as a Multimodality Regulator of Tumor-Mediated Immune Suppression and Therapeutic Target in Gliomas
    Jun Yan, Ling-Yuan Kong, Jiemiao Hu, Konrad R. Gabrusiewicz, Denada Dibra, Xueqing Xia, Amy B. Heimberger, Shulin Li · 2015 · JNCI Journal of the National Cancer Institute
  94. Tissue factor expression provokes escape from tumor dormancy and leads to genomic alterations
    Nathalie Magnus, Delphine Garnier, Brian Meehan, Serge McGraw, Tae Hoon Lee, Maxime Caron, Guillaume Bourque, Chlöe Milsom, Nada Jabado, Jacquetta M. Trasler et al. · 2014 · Proceedings of the National Academy of Sciences
  95. Pro-inflammatory Aorta-Associated Macrophages Are Involved in Embryonic Development of Hematopoietic Stem Cells
    Samanta Antonella Mariani, Zhuan Li, Siobhan Rice, Carsten Krieg, Stamatina Fragkogianni, Mark D. Robinson, Chris Sebastiaan Vink, Jeffrey W. Pollard, Elaine Anne Dzierzak · 2019 · Immunity
  96. Biologically Responsive Plasmonic Assemblies for Second Near-Infrared Window Photoacoustic Imaging-Guided Concurrent Chemo-Immunotherapy
    Rong Zhu, Lichao Su, Jiayong Dai, Zhan‐Wei Li, Shumeng Bai, Qingqing Li, Xiaoyuan Shawn Chen, Jibin Song, Huanghao Yang · 2020 · ACS Nano
  97. Inflammation fires up cancer metastasis
    Bin‐Zhi Qian · 2017 · Seminars in Cancer Biology
  98. The evolving landscape of ‘next-generation’ immune checkpoint inhibitors: A review
    Luca Mazzarella, Bruno Achutti Duso, Dario Trapani, Carmen Belli, Paolo D’Amico, Emanuela Ferraro, Giulia Viale, Giuseppe Curigliano · 2019 · European Journal of Cancer
  99. Interactions between Tumor Cells, Neurons, and Microglia in the Glioma Microenvironment
    Daniel P. Radin, Stella E. Tsirka · 2020 · International Journal of Molecular Sciences
  100. Metabolism and polarization regulation of macrophages in the tumor microenvironment
    Jia Wang, Shichao Mi, Muyao Ding, Xue Li, Shengtao Yuan · 2022 · Cancer Letters